PCOS Phenotypes: Understanding the Four Faces of the Syndrome

Introduction

PCOS is not a single, uniform condition — it is a syndrome with significant heterogeneity. Women with PCOS can look quite different from each other: one woman may have severe hirsutism and regular cycles; another may have polycystic ovaries and irregular periods with no visible androgen excess. This diversity prompted the NIH to formally classify PCOS into four phenotypes in 2012, based on combinations of the three Rotterdam criteria.

The Four PCOS Phenotypes

Phenotype A: "Classic" PCOS (Hyperandrogenism + Anovulation + Polycystic Ovaries)

This is the most common and most severe phenotype. Women have all three Rotterdam features: clinical and/or biochemical hyperandrogenism, irregular/absent periods (oligo/anovulation

Phenotype B: "Classic" without PCO (Hyperandrogenism + Anovulation, but Normal Ovaries)

Women have clinical/biochemical hyperandrogenism and irregular cycles but their ovaries look normal on ultrasound. This phenotype has similar hormonal and metabolic derangements to Phenotype A — high LH:FSH ratio, elevated androgens, insulin resistance. The absence of polycystic morphology does not lessen the clinical significance. This phenotype may be underdiagnosed if ultrasound findings are over-weighted.

Phenotype C: "Ovulatory" PCOS (Hyperandrogenism + Polycystic Ovaries, but Regular Cycles)

Ovulatory PCOS is a controversial phenotype. Women have elevated androgens and polycystic ovaries but maintain regular menstrual cycles and (apparently) ovulate. They may still have subtle ovulatory defects (impaired luteal phase, diminished midcycle LH surge). Metabolic risk is intermediate between phenotypes A/B and D. Importantly, fertility is often preserved.

Phenotype D: "Non-androgenic" PCOS (Anovulation + Polycystic Ovaries, but No Hyperandrogenism)

Women have irregular cycles and polycystic-appearing ovaries but no clinical or biochemical evidence of androgen excess. This is the mildest phenotype, with the lowest metabolic risk of the four. Some experts question whether this truly represents PCOS or a different condition (e.g. hypothalamic amenorrhoea with polycystic morphology). This phenotype is not recognised by the Androgen Excess Society criteria, which require hyperandrogenism for PCOS diagnosis.

Why Phenotype Matters

Metabolic Risk Stratification

Phenotypes A and B carry the highest risk of insulin resistance, metabolic syndrome, and type 2 diabetes. Women with these phenotypes should be screened more aggressively — OGTT, lipid profile, blood pressure monitoring. Phenotype D has the lowest metabolic risk.

Fertility Implications

Phenotypes A and B have the greatest anovulation and therefore the greatest barriers to natural conception. They typically require ovulation induction more often. Phenotype C may be able to conceive naturally, though cycle timing can be challenging. Phenotype D may have intermittent ovulation.

Treatment Tailoring

• Phenotype A/B: Lifestyle change is critical. Metformin for insulin resistance. COCs for cycle regulation and hyperandrogenism. Letrozole for ovulation induction.
• Phenotype C: Focus on treating hyperandrogenism symptoms (hirsutism
• acne). Metabolic screening is still important.
• Phenotype D: Confirm diagnosis — rule out hypothalamic amenorrhoea (the most important differential). If confirmed
• manage cycle regularity to prevent unopposed estrogen exposure; fertility evaluation as needed.

A Practical Note on Phenotype Identification

In clinical practice, phenotyping requires a systematic assessment of:

• Menstrual history (cycle frequency
• regularity)
• Clinical androgen signs (modified Ferriman-Gallwey score for hirsutism; acne pattern; hair thinning)
• Biochemical androgens (free testosterone
• DHEA-S
• SHBG)
• Ultrasound or AMH
• Exclusion of other conditions (thyroid
• prolactin
• late-onset CAH)

References: NIH Evidence-Based Methodology Workshop on PCOS 2012; Azziz R et al., PCOS phenotypes, J Clin Endocrinol Metab 2006; 2023 International PCOS Guideline.